Literature DB >> 16799027

Effects of orthoptic treatment on the CA/C and AC/A ratios in convergence insufficiency.

Rune L Brautaset1, Adrian J M Jennings.   

Abstract

PURPOSE: To evaluate the effect of orthoptic treatment on the AC/A (A, accommodation; C, convergence) and CA/C ratios in subjects with convergence insufficiency (CI).
METHODS: The change in AC/A and CA/C ratios after a 12-week period of home-based orthoptic treatment was examined in 10 subjects (mean age, 25.4+/-4.1 years [SD]). Both the AC/A and CA/C ratios were measured by using gradient response methods. For the AC/A ratio, the gradient phoria method was used, and for the CA/C ratio the prism-induced change in accommodation was measured with a refractometer.
RESULTS: No change in the AC/A and CA/C ratios (P>0.05) were found after orthoptic treatment. However, improvements were found (P<0.05) in the fast and slow vergence mechanisms.
CONCLUSIONS: Despite improvements in the fast and slow vergence mechanisms no change was found in the AC/A and CA/C ratios after orthoptic treatment in CI subjects. This finding is unexpected in light of the present understanding of CI, and an alternative theory is proposed.

Entities:  

Mesh:

Year:  2006        PMID: 16799027     DOI: 10.1167/iovs.04-1372

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

1.  Vision therapy in adults with convergence insufficiency: clinical and functional magnetic resonance imaging measures.

Authors:  Tara L Alvarez; Vincent R Vicci; Yelda Alkan; Eun H Kim; Suril Gohel; Anna M Barrett; Nancy Chiaravalloti; Bharat B Biswal
Journal:  Optom Vis Sci       Date:  2010-12       Impact factor: 1.973

2.  Comparison of symmetrical prism adaptation to asymmetrical prism adaptation in those with normal binocular vision.

Authors:  Elio M Santos; Chang Yaramothu; Tara L Alvarez
Journal:  Vision Res       Date:  2018-06-28       Impact factor: 1.886

3.  The Convergence Insufficiency Neuro-mechanism in Adult Population Study (CINAPS) Randomized Clinical Trial: Design, Methods, and Clinical Data.

Authors:  Tara L Alvarez; Mitchell Scheiman; Elio M Santos; Cristian Morales; Chang Yaramothu; John Vito D'Antonio-Bertagnolli; Bharat B Biswal; Suril Gohel; Xiaobo Li
Journal:  Ophthalmic Epidemiol       Date:  2019-10-22       Impact factor: 1.648

4.  Short-term adaptations of the dynamic disparity vergence and phoria systems.

Authors:  Eun H Kim; Vincent R Vicci; Bérangère Granger-Donetti; Tara L Alvarez
Journal:  Exp Brain Res       Date:  2011-05-19       Impact factor: 1.972

Review 5.  Symptomatology associated with accommodative and binocular vision anomalies.

Authors:  Ángel García-Muñoz; Stela Carbonell-Bonete; Pilar Cacho-Martínez
Journal:  J Optom       Date:  2014-07-15

6.  Concurrent vision dysfunctions in convergence insufficiency with traumatic brain injury.

Authors:  Tara L Alvarez; Eun H Kim; Vincent R Vicci; Sunil K Dhar; Bharat B Biswal; A M Barrett
Journal:  Optom Vis Sci       Date:  2012-12       Impact factor: 1.973

7.  Spherical lenses and prisms lead to postural instability in both dyslexic and non dyslexic adolescents.

Authors:  Zoi Kapoula; Chrystal Gaertner; Eric Matheron
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

8.  Sustained fixation induced changes in phoria and convergence peak velocity.

Authors:  Eun H Kim; Vincent R Vicci; Sang J Han; Tara L Alvarez
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

9.  Diagnostic validity of clinical signs associated with a large exophoria at near.

Authors:  Pilar Cacho-Martínez; Angel García-Muñoz; María Teresa Ruiz-Cantero
Journal:  J Ophthalmol       Date:  2013-06-17       Impact factor: 1.909

10.  The effectiveness of home-based pencil push-up therapy versus office-based therapy for the treatment of symptomatic convergence insufficiency in young adults.

Authors:  Hamed Momeni-Moghaddam; James Kundart; Abbas Azimi; Farzaneh Hassanyani
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.